JP2021530482A5 - - Google Patents

Info

Publication number
JP2021530482A5
JP2021530482A5 JP2021500520A JP2021500520A JP2021530482A5 JP 2021530482 A5 JP2021530482 A5 JP 2021530482A5 JP 2021500520 A JP2021500520 A JP 2021500520A JP 2021500520 A JP2021500520 A JP 2021500520A JP 2021530482 A5 JP2021530482 A5 JP 2021530482A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
acid
tumor
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021500520A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021530482A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/040264 external-priority patent/WO2020023191A1/en
Publication of JP2021530482A publication Critical patent/JP2021530482A/ja
Publication of JP2021530482A5 publication Critical patent/JP2021530482A5/ja
Withdrawn legal-status Critical Current

Links

JP2021500520A 2018-07-09 2019-07-02 腫瘍を減少させる製剤およびその使用方法 Withdrawn JP2021530482A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862695613P 2018-07-09 2018-07-09
US62/695,613 2018-07-09
PCT/US2019/040264 WO2020023191A1 (en) 2018-07-09 2019-07-02 Tumor reduction formulations and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2021530482A JP2021530482A (ja) 2021-11-11
JP2021530482A5 true JP2021530482A5 (https=) 2022-07-07

Family

ID=75267393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021500520A Withdrawn JP2021530482A (ja) 2018-07-09 2019-07-02 腫瘍を減少させる製剤およびその使用方法

Country Status (11)

Country Link
EP (1) EP3820482A4 (https=)
JP (1) JP2021530482A (https=)
KR (1) KR20220098082A (https=)
CN (1) CN112584841A (https=)
AU (1) AU2019309757A1 (https=)
BR (1) BR112021000279A8 (https=)
CA (1) CA3105717A1 (https=)
EA (1) EA202190201A1 (https=)
IL (1) IL280000A (https=)
PH (1) PH12021550033A1 (https=)
WO (1) WO2020023191A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220152051A1 (en) * 2019-03-15 2022-05-19 Dalian University Application of glycocholic acid in preparation of antitumor drugs
WO2020232227A1 (en) 2019-05-14 2020-11-19 Tyme, Inc. Compositions and methods for treating cancer
US20210169903A1 (en) * 2019-12-09 2021-06-10 Tyme, Inc. Pharmaceutical compositions and methods
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050202094A1 (en) * 2004-01-29 2005-09-15 Werling Jane O. Nanosuspensions of anti-retroviral agents for increased central nervous system delivery
WO2006099685A1 (en) * 2005-03-24 2006-09-28 Medical Therapies Limited Method for the prophylaxis or treatment of carcinomas
CN101023940A (zh) * 2006-02-20 2007-08-29 郝守祝 一种紫杉烷类化合物的药用组合物、制备方法及用途
WO2016007741A1 (en) * 2014-07-11 2016-01-14 The Regents Of The University Of California Tumor selective macropinocytosis-dependent rapidly internalizing antibodies
US9687528B2 (en) * 2014-12-23 2017-06-27 Steven Hoffman Transdermal formulations
EP3429583A1 (en) * 2016-03-15 2019-01-23 Tyme, Inc. Pharmaceutical compositions for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2021530482A5 (https=)
Sakaguchi et al. Polyglycolic acid sheets with fibrin glue can prevent esophageal stricture after endoscopic submucosal dissection
EA201790124A1 (ru) Соли берберина, соли урсодезоксихолевой кислоты и их комбинации, способы получения и применения
JP2011511076A5 (https=)
JP2017518302A5 (https=)
EA032908B1 (ru) Конъюгаты антитело-лекарственное средство (adc), которые связываются с белками 158p1d7
JP2016505612A5 (https=)
Kim et al. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism
WO2013133873A3 (en) Pharmaceutical compositions of sodium ion and calcium ion and methods for treating cancer, tumor and non-malignancy
Ishizuka et al. Experimental evaluation of photocrosslinkable chitosan hydrogel as injection solution for endoscopic resection
Eberspacher et al. Transperineal excision of malignant peripheral nerve sheath tumors of the ischiorectal fossa: case report of a rare tumor in a frequently forgotten anatomical region
JP2014517038A5 (https=)
JP2017533928A5 (https=)
Wei et al. High-intensity focused ultrasound leads to histopathologic changes of the inferior turbinate mucosa with allergic inflammation
Mateshuk-Vatseba et al. Morphological features of the wall of common bile duct under the conditions of experimental opioid exposure
Prachayakul et al. Spraying N-butyl-2-cyanoacrylate (Histoacryl) as a rescue therapy for gastrointestinal malignant tumor bleeding after failed conventional therapy
RU2847886C1 (ru) Способ мини-инвазивного лечения нейроэндокринных опухолей поджелудочной железы
Bradley History of head and neck surgery
Mateshuk-Vatseba e-mail: lvatseba@ gmail. com
Dupré et al. High Intensity Focused Ultrasound (HIFU) in Digestive Diseases: An Overview of Clinical Applications for Liver and Pancreatic Tumors
Althaqfi et al. Results of brachytherapy in anal cancer from a cohort of 173 patients treated at the same institution over a 20 year period
Zhong et al. Electrochemical treatment: an effective way of dealing with extensive venous malformations of the oral and cervicofacial region
Алексеев et al. Discussion on problems of prostate cancer treatment and the role of cabazitaxel in treatment of patients with metastatic castration-resistant prostate cancer: Decision of the Expert Board
BR112022012335A2 (pt) Peptídeo, composição, métodos para tratar um paciente e para tratar uma doença, e, uso de um peptídeo
Weigt et al. Endoscopic intraductal radiofrequency ablation of remnant intrapapillary mucinous neoplasm with acute hemorrhage after incomplete surgical resection